The arterial switch operation (ASO) for transposition of the great arteries (TGA) and ventricular septal defect (VSD) is currently the best treatment option. [1] [2] [3] With timely diagnosis, most children with TGA/VSD usually undergo surgical correction within the first 1 to 3 months after birth. In developing countries, however, for socioeconomic reasons, some of these children unfortunately are brought for surgical correction when they are beyond 6 months of age with severe pulmonary hypertension (PH) owing to pulmonary vascular obstructive disease (PVOD). 4 In general, patients with isolated VSD and PH with pulmonary vascular resistance (PVR) in excess of 8 U/m 2 are considered inoperable. In 1972 Lindesmith and associates 5 first reported a series of patients who presented late with TGA/VSD and PVOD and subsequently underwent palliative atrial switch operations with the VSDs left open. This approach, however, was associated with long-term symptomatic arrhythmia and baffle obstruction. 6, 7 During the past decade, several case reports of palliative ASO for late presentation of TGA/ VSD with PVOD were contributed by Pridjian, 8 Elizari, 9 and their colleagues. This present report is, to our knowledge, the first article to analyze a series of patients with TGA/VSD and severe PVOD who were treated by palliative ASO.
PATIENTS AND METHODS
Between March 2000 and September 2009, 21 children with TGA, moderate to large VSD, and PVOD underwent palliative ASO in our institution. Approval was obtained by the institutional review board. The medical records of these patients, specifically patient demographics, preoperative and postoperative hemodynamics and functional status, operative procedures, 30-day hospital mortality and major morbidity, and all the investigative data during the follow-up period were reviewed and analyzed.
Seventeen children were male. Mean age at the time of palliative ASO was 3.7 AE 3.4 years (range, 0.5-15 years). Preoperative New York Heart Association (NYHA) functional class was available in all the patients: 4 (19%) patients were in class II, 12 (57%) patients were in class III, and 5 (24%) were in class IV. Thirteen patients required preoperative digitalis and diuretic therapy. None of the patients had any prior cardiac surgical procedures performed.
Anatomic diagnoses are shown in Table 1 . Cardiac catheterization data were available in 17 (81%) patients. The mean preoperative PVR was 18.3 AE 11.6 U $ m 2 (range, 7.8-45 U $ m 2 ), which after phentolamine administration decreased to 16.6 AE 10.5 U $ m 2 (range, 7.0-42 U $ m 2 ). The mean peak systolic pulmonary arterial pressure was 91 AE 13 mm Hg (range, 68-115 mm Hg). The mean preoperative systolic pulmonary/systemic arterial pressure ratio was 0.99 AE 0.10 (range, 0.79-1.20). The mean preoperative oxygen saturation and hematocrit value were 69% AE 9.5% (range, 48%-86%) and 60% AE 12% (28%-76%), respectively. Early mortality was defined as death occurring within 30 days of operation or at any time during the operative hospitalization. All patients discharged from the hospital were followed up to the end date of the study (September 2009). The patients were asked to return to the hospital for echocardiographic and clinical evaluations at 3 and 6 postoperative months and then at least once each year.
All analyses were performed using SPSS statistical software (SPSS, Inc, Chicago, Ill). Preoperative and postoperative continuous variables were compared using paired-samples t tests. Comparisons of preoperative data between those who subsequently displayed persistent severe PH and those who showed reversible PVOD after palliative ASO were drawn using the independent-samples t test. Changes in preoperative and postoperative New York Heart Association classification were analyzed using the Wilcoxon test.
RESULTS
All the operations were performed through a median sternotomy with cardiopulmonary bypass. All the patients underwent ASO as described by current congenital heart surgery textbooks. Two early cases were performed without closing the VSDs, whereas in all the others the VSDs were closed using either autologous pericardium, treated with 0.6% glutaraldehyde for 15 minutes (n ¼ 11), or polytetrafluoroethylene (n ¼ 8) fenestrated patches. The diameters of fenestrations varied from 4 to 10 mm. The sizes of fenestrations were determined according to one half the expected aortic annulus size for each child. Associated cardiac procedures included patent ductus arteriosus ligation in 8, atrial septal defect repair in 5, and aortopulmonary window repair in 1 patient. The median aortic occlusion time was 148 minutes (range, 84-193 minutes). Deep hypothermic circulatory arrest was used in 4 patients. The median postoperative mechanical ventilation time was 22 hours (range, 4-410 hours).
Early mortality was 14.3% (3 patients). Causes of early death were cardiac failure, sudden cardiac arrest induced by pulmonary hypertensive crisis, and persistent pulmonary hemorrhage in 1 patient each. The patient who died of cardiac failure was seen early on in our experience. He was 5 years old at the time of operation with a single coronary ostium at the right coronary sinus giving rise to the right coronary, the left anterior descending, and the left circumflex arteries. The VSD was left open. He could not be weaned from cardiopulmonary bypass. We believed that the cause of death was myocardial ischemia owing to less than ideal transfer of the single coronary button. Another 5-year-old child died of sudden cardiac arrest 5 days after palliative ASO and extubated for 3 days. His VSD was closed with a pericardial patch with a 6-mm fenestration. Severe PH and right-to-left shunt were found on postoperative echocardiography. We believed that his cardiac arrest was induced by pulmonary hypertensive crisis. The patient who died of persistent pulmonary hemorrhage was also found to have severe PH on postoperative echocardiography. We again believed that the pulmonary hemorrhage was related to PH. Nitric oxide and sildenafil were both used in the last 2 patients postoperatively. Oral sildenafil, inhaled nitric oxide, and continuous intravenous prostacyclin were selectively used postoperatively in most of the patients in this cohort according to the conditions of each patient.
The median postoperative length of stay for the early survivors was 17 days (range, 7-33 days). Eight patients had major morbidities including pleural effusion requiring thoracentesis (n ¼ 2), pneumonia requiring prolonged (>72 hours) antimicrobial therapy (n ¼ 3), acute renal failure requiring peritoneal dialysis before discharge (n ¼ 1), and mediastinal re-exploration for bleeding (n ¼ 2). At late follow-up, the mean systemic arterial oxygen saturation increased from 69% preoperatively to 93% postoperatively (P < .001), and the mean hematocrit value decreased from 60% preoperatively to 43% (P < .001; Table 2 ).
The mean follow-up for the 18 early survivors was 4.0 years with a maximum of 9.5 years. There was 1 late death that occurred 3 months after surgery (Figure 1 ). The estimated postoperative pulmonary pressure, obtained by echocardiography just before discharge in the patient who died late, was 45 mm Hg. The cause of late death was sudden cardiac arrest in an outlying hospital. The details surrounding this death were not clear. Three patients with preoperative PVR of 20, 15, and 12 U $ m 2 , respectively, underwent percutaneous closure using Amplatzer occluder devices of their VSD patch fenestrations when persistent left-to-right shunts at the ventricular level and normal-to-mild (<50 mm Hg) estimated systolic pulmonary arterial pressures were documented on Doppler echocardiograms 7, 9, and 31 months after their palliative ASO, respectively. Four other patients who were documented to have left-to-right shunts at the ventricular level and mild-to-moderate (50-70 mm Hg) estimated systolic pulmonary arterial pressures by Doppler echocardiograms were advised to continue watchful follow-up periodically. In 1 patient who underwent concomitant aortopulmonary window (type I) repair and palliative ASO, Doppler echocardiography 10 months later found a spontaneously closed fenestration and normal pulmonary arterial pressure. She is alive and well at the time of this (Table 3 ). There were no significant differences in age, preoperative PVR (including PVR after phentolamine infusion), systolic pulmonary/systemic arterial pressure ratio, oxygen saturation, and hematocrit between these 9 patients and those who demonstrated postoperative regression of their PH (P > .05, Table 4 ). The indications for percutaneous closure of fenestrations are (1) stable hemodynamics and good cardiopulmonary function and (2) persistent left-to-right shunt and estimated systolic pulmonary arterial pressure less than 50 mm Hg documented by 2 consecutive Doppler echocardiograms over a period of 6 months.
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During the follow-up period, 1 patient had moderate aortic valve regurgitation, 2 had mild coarctation of the aorta, 1 had mild mitral valve regurgitation, and 2 had mild-tomoderate tricuspid insufficiency; none of these required surgical intervention.
NYHA functional class was available in 17 of the 18 early survivors. Functional class was significantly improved postoperatively: 13 patients were in class I and 4 in class II (P < .001, Figure 2 ). Electrocardiographic data were available in 17 patients, all showing sinus rhythms.
COMMENT
ASO has been proved to be the preferred choice for most neonates with TGA. [1] [2] [3] Pulmonary vascular disease in children with TGA progresses rapidly during early infancy. In TGA associated with VSD with or without patent ductus arteriosus, the development of PVOD is faster owing to high pulmonary blood flow, high pulmonary artery pressure, hypoxemia, and polycythemia. Delayed diagnosis could result in progressive PVOD. Palliative atrial switch operation has been attempted to treat patients with TGA, VSD, and severe PVOD in the past with apparently good long-term results. 5, 6 However, a not insignificant portion of this patient population experienced symptomatic or even deadly arrhythmia and reoperation for baffle obstruction.
6,7 Pridjian, 8 Elizari, 9 and SaO 2, Arterial oxygen saturation; Hct, hematocrit; PVR, pulmonary vascular resistance; PVR 0 , preoperative PVR after phentolamine administration. *Data were unavailable on some patients. Oxygen saturation data were obtained on room air; ypostoperative hematocrit was obtained at late follow-up; zpreoperative PVR versus PVR after phentolamine administration, P ¼ .006; xpreoperative systemic oxygen saturation versus postoperative arterial saturation, P<.001; kpreoperative hematocrit versus postoperative hematocrit, P<.001. their colleagues reported the application of palliative ASO in 2 patients without closing the VSDs and both patients enjoyed near normal lives postoperatively, although their PVOD did not improve. By contrast, Nakajima and associates 10 reported a series of 19 patients (ages ranging from 7 months to 14 years) with TGA with or without VSD and all with severe PH who underwent the atrial switch operation or ASO, with some patients showing improvement of their PVOD postoperatively. In our series, except the 2 patients early on in our experience whose VSDs were left open, all the other patients undergoing palliative ASO had their VSDs closed with fenestrated patches. This approach offers the distinct advantage of subsequent nonsurgical closure of the residual shunt when echocardiography during followup demonstrates persistent left-to-right shunt and acceptable estimated systolic pulmonary arterial pressure compared with simply leaving the VSD open during the palliative ASO. In our study, 8 of the 18 early survivors showed a significant decrease of pulmonary arterial pressure, with 4 of them eventually achieving complete VSD closures. The indication for palliative ASO can also be extended to patients with TGA and intact ventricular septum and severe PVOD in whom a VSD is created at the time of palliative ASO 11 and patients with other transposition hemodynamics, VSD (eg, Taussig-Bing anomaly), and severe PVOD. 12, 13 Our decision to size the fenestration was based on one half of the expected aortic annulus diameter of the child. We believe that half the aortic annulus size is large enough to decompress the right ventricle. Novick and coworkers 14 reported a large group of fenestrated flap valve double patch closure of VSD in children with elevated PVR in 2005. They sized the fenestration in a similar fashion as we did and achieved a good result. Some researchers believe that the size of the fenestration must be nearly the size of the aortic annulus (nonrestrictive) to provide effective right ventricular decompression. However, any postoperative regression of pulmonary arterial pressure will be masked by massive left-to-right shunt affected or even sustained by the nonrestrictive fenestration.
Haworth, Radley, and Yacoub 15 analyzed lung biopsy tissue of patients with TGA/VSD and found that increased PVR was associated with cellular intimal proliferation without developing the classic grade III and IV pulmonary vascular disease characterized by intimal fibrosis and dilation. PVR will increase when most of the pulmonary arteries are narrowed and also when the pulmonary arteries are fewer than normal. There are more intra-acinar pulmonary arteries than normal in certain congenital heart lesions such as aortic atresia and stenosis and fewer in pulmonary atresia. 16, 17 Therefore, certain lesions such as TGA/VSD and truncus arteriosus, which develop an early increase in PVR, might have fewer intra-acinar pulmonary arteries at term. In normal children, there is a continued increase in the number of intra-acinar arteries after birth until lung growth is completed by 8 to10 years of age. 18, 19 The capability of regeneration of intra-acinar arteries in children with TGA/ VSD is not known. However, these findings suggest that the potential capacity of regeneration of pulmonary vessels may lead to the potential reversibility of PVOD after surgery. 4 On the other hand, some patients with TGA have severe irreversible PVOD develop in early infancy, 20 even after successful surgery. 21, 22 The pathologic differences between these 2 groups of patients with reversible and irreversible PVOD may contribute to the distinct outcomes of these patients. 23 ASO for TGA has shown very low (2%-5%) early mortality. 24, 25 However, reports of palliative ASO for TGA/ VSD with PVOD are few and the clinical data currently available are still insufficient for any meaningful interpretation. Burkhart and coworkers 7 reported a series of patients who underwent palliative atrial switch for TGA/VSD with PVOD with an early mortality of 21% and a 15-year survival of 54%. Our study showed an early mortality of 14.3% and a late mortality of 5.6% during a mean follow-up period of 4 years. These figures appeared acceptable considering the poor prognosis of children with TGA/VSD and PVOD if untreated.
Although our postoperative treatment protocol including nitric oxide, prostacyclin, and sildenafil has been used to manage PH and improve hemodynamics, 2 of the 3 early deaths were still related to severe PH, indicating that severe postoperative PH was still a major threat to survival. Extracorporeal membrane oxygenator support might be an option to salvage postoperative patients with unstable hemodynamics and cardiopulmonary dysfunction.
In contrast to the atrial switch procedure, palliative ASO seems to have fewer long-term complications such as symptomatic or even deadly arrhythmias and baffle obstruction, which might require reoperative intervention, and therefore should be considered as another option in the congenital heart surgeons' armamentarium. Longer-term follow-up (10 years and more) as well as a prospective randomized trial comparing the palliative atrial switch operation and palliative ASO may ultimately define the true validity of both procedures in dealing with these groups of unfortunate children with late presentation of TGA/VSD and severe PVOD in many developing countries of the world.
In conclusion, palliative ASO can be performed in patients with TGA/VSD and severe PVOD. Postoperative PVR might be reversible in some patients. Closing the VSD with a fenestrated patch is suggested for further possible percutaneous occlusion of fenestration. Systemic arterial saturation and quality of life can be significantly improved. Low incidence of long-term complications and reoperation might be the advantage over the palliative atrial switch procedure.
